{"cveId": "CVE-2021-43935", "cwe": ["CWE-288", "CWE-287", "CWE-288", "CWE-287"], "cvss": [{"baseScore": "8.1", "version": "3.1", "Attack Vector": "None", "Attack Complexity": "High", "Privileges Required": "None", "User Interaction": "None", "Scope": "Unchaged", "Confidentiality Impact": "High", "Integrity Impact": "High", "Availability Impact": "High"}], "references": ["https://www.cisa.gov/uscert/ics/advisories/icsma-21-343-01"], "description": ["The impacted products, when configured to use SSO, are affected by an improper authentication vulnerability. This vulnerability allows the application to accept manual entry of any active directory (AD) account provisioned in the application without supplying a password, resulting in access to the application as the supplied AD account, with all associated privileges."], "published": "2021-12-15T19:15:15.873", "state": "PUBLIC", "vendorName": ["Hillrom"], "productName": ["Welch Allyn Q-Stress Cardiac Stress Testing System", "Welch Allyn X-Scribe Cardiac Stress Testing System", "Welch Allyn Diagnostic Cardiology Suite", "Welch Allyn Vision Express", "Welch Allyn H-Scribe Holter Analysis System", "Welch Allyn R-Scribe Resting ECG System", "Welch Allyn Connex Cardio"], "github": {"advisories": [], "commits": [], "pocAdvisorie": null, "repo": null, "info": {}}, "pocList": []}